首页 | 本学科首页   官方微博 | 高级检索  
     


Potential of adenovirus‐mediated REIC/Dkk‐3 gene therapy for use in the treatment of pancreatic cancer
Authors:Daisuke Uchida  Hidenori Shiraha  Hironari Kato  Teruya Nagahara  Masaya Iwamuro  Junro Kataoka  Shigeru Horiguchi  Masami Watanabe  Akinobu Takaki  Kazuhiro Nouso  Yasutomo Nasu  Takahito Yagi  Hiromi Kumon  Kazuhide Yamamoto
Affiliation:1. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, , Okayama, Japan;2. Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, , Okayama, Japan;3. Innovation Center Okayama for Nanobio‐Targeted Therapy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, , Okayama, Japan;4. Department of Molecular Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, , Okayama, Japan;5. Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, , Okayama, Japan
Abstract:
Keywords:apoptosis  autophagy  dickkopf‐related protein  gene therapy  mTOR pathway
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号